Gastrinoma medical therapy

	Gastrinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Gastrinoma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gastrinoma medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gastrinoma medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gastrinoma medical therapy
CDC on Gastrinoma medical therapy
Gastrinoma medical therapy in the news
Blogs on Gastrinoma medical therapy
Directions to Hospitals Treating Gastrinoma
Risk calculators and risk factors for Gastrinoma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Proton pump inhibitors (PPI): This kind of drugs can effectively reduce gastric acid secretion in the stomach. Usual drugs include esomeprazole, lansoprazole, pantoprazole and omeprazole.
Chemotherapy: For those the tumor can not be surgically removed, chemotherapy is available. The drugs include streptozotocin, 5-fluorouracil (Adrucil) and doxorubicin.